These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16206288)

  • 1. Disruption of the p53-p53r2 DNA repair system in ulcerative colitis contributes to colon tumorigenesis.
    Yoshida T; Haga S; Numata Y; Yamashita K; Mikami T; Ogawa T; Ohkusa T; Okayasu I
    Int J Cancer; 2006 Mar; 118(6):1395-403. PubMed ID: 16206288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and mutation analyses of P53R2, a newly identified p53 target for DNA repair in human gastric carcinoma.
    Byun DS; Chae KS; Ryu BK; Lee MG; Chi SG
    Int J Cancer; 2002 Apr; 98(5):718-23. PubMed ID: 11920641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells.
    Liu X; Zhou B; Xue L; Shih J; Tye K; Lin W; Qi C; Chu P; Un F; Wen W; Yen Y
    Clin Cancer Res; 2006 Nov; 12(21):6337-44. PubMed ID: 17085643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage.
    Tanaka H; Arakawa H; Yamaguchi T; Shiraishi K; Fukuda S; Matsui K; Takei Y; Nakamura Y
    Nature; 2000 Mar; 404(6773):42-9. PubMed ID: 10716435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
    Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
    Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.
    Yamaguchi T; Matsuda K; Sagiya Y; Iwadate M; Fujino MA; Nakamura Y; Arakawa H
    Cancer Res; 2001 Nov; 61(22):8256-62. PubMed ID: 11719458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the p53R2 ribonucleotide reductase subunit by nitric oxide.
    Guittet O; Tebbi A; Cottet MH; Vésin F; Lepoivre M
    Nitric Oxide; 2008 Sep; 19(2):84-94. PubMed ID: 18474260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1 regulates p53R2 gene expression in p53-deficient cells.
    Qi JJ; Liu L; Cao JX; An GS; Li SY; Li G; Jia HT; Ni JH
    Mol Cell Biochem; 2015 Jan; 399(1-2):179-88. PubMed ID: 25312903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of the DNA repair and growth arrest pathways by p53R2 silencing enhances DNA damage-induced apoptosis in a p53-dependent manner in prostate cancer cells.
    Devlin HL; Mack PC; Burich RA; Gumerlock PH; Kung HJ; Mudryj M; deVere White RW
    Mol Cancer Res; 2008 May; 6(5):808-18. PubMed ID: 18505925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer.
    Liu X; Zhou B; Xue L; Yen F; Chu P; Un F; Yen Y
    Clin Colorectal Cancer; 2007 Jan; 6(5):374-81. PubMed ID: 17311703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
    Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
    Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53R2, newly p53 target in oral normal epithelium, epithelial dysplasia and squamous cell carcinoma.
    Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
    Cancer Lett; 2003 Feb; 190(2):233-43. PubMed ID: 12565178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53R2 is a prognostic factor of melanoma and regulates proliferation and chemosensitivity of melanoma cells.
    Matsushita S; Ikeda R; Fukushige T; Tajitsu Y; Gunshin K; Okumura H; Ushiyama M; Akiyama S; Kawai K; Takeda Y; Yamada K; Kanekura T
    J Dermatol Sci; 2012 Oct; 68(1):19-24. PubMed ID: 22902076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
    Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
    J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin.
    Azimi A; Majidinia M; Shafiei-Irannejad V; Jahanban-Esfahlan R; Ahmadi Y; Karimian A; Mir SM; Karami H; Yousefi B
    Gene; 2018 Feb; 642():249-255. PubMed ID: 29126924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA.
    Nardinocchi L; Puca R; Sacchi A; D'Orazi G
    Biochem Biophys Res Commun; 2007 Sep; 361(1):249-55. PubMed ID: 17658469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt phosphorylation in human chondrocytes is regulated by p53R2 in response to mechanical stress.
    Kawakita K; Nishiyama T; Fujishiro T; Hayashi S; Kanzaki N; Hashimoto S; Takebe K; Iwasa K; Sakata S; Nishida K; Kuroda R; Kurosaka M
    Osteoarthritis Cartilage; 2012 Dec; 20(12):1603-9. PubMed ID: 22954457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
    Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
    Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease.
    Goodman JE; Hofseth LJ; Hussain SP; Harris CC
    Environ Mol Mutagen; 2004; 44(1):3-9. PubMed ID: 15199542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.